Retinalyze, LLC Enters Into An Exclusive Agreement With NATIONAL EYEPA COALITION

Health Discovery Corporation (OTCBB: HDVY), a molecular diagnostics leader in the use of patent protected advanced mathematical techniques for personalized medicine, and Doctors Optimal Formula LLC , a physician exclusive anti-aging, health and wellness company have entered into an exclusive agreement for their 50%/50% joint venture, Retinalyze, LLC as a preferred vendor with National Coalition of Eye Care IPAs (NATIONAL EYEPA COALITION).

As a result of Retinalyze being launched at February 2012’s Heart of America Convention, national exposure for this ground breaking technology has been overwhelmingly received by top Eye Doctors. Recognizing the benefits of Retinalyze, LLC's Support Vector Machine-based macular degeneration risk assessment technology, the NATIONAL EYEPA COALITION has been granted exclusivity for optometrists in return for meeting specified minimum guaranteed performance goals. The NATIONAL EYEPA COALITION will begin immediately utilizing the technology and with monthly ramp ups expects to have their member doctors performing a minimum of 110,000 scans monthly by January 15, 2013 at a cost of $9.95 per scan plus $19.95 per month per doctor service fee to maintain their exclusivity.

“With approximately 5,500 Eye Doctors in their group, we are incredibly excited to have executed this contract with the NATIONAL EYEPA COALITION,” states Howard Loff, MD, CEO of Retinalize, LLC.

According to Dan Dieterichs, OD, President of the NATIONAL EYEPA COALITION, “We are proud to announce our partnership with Retinalyze, LLC. This partnership will bring exclusive new pattern recognition SVM technology to the IPA physicians which will provide additional information for them to utilize in their decision making process in diagnosing chronic retinal diseases. Furthermore, the exclusive arrangement will allow the IPA doctors to communicate with primary care physicians, better integrating them in the health care delivery chain for their patients. Our provider networks will be better able to provide and coordinate care for our patients.”

Retinalyze, LLC currently offers an Age-related Macular Degeneration (AMD) module. AMD is the leading cause of blindness in US adults 55 years and older and is a progressive eye disease affecting more than 15 million Americans, with over 200,000 new cases diagnosed each year.

“Using Retinalyze, LLC's proprietary technology, patients with AMD can be identified earlier,” notes Howard Loff, MD, “thereby enabling these patients to begin treatment earlier which could significantly improve their prognosis and quality of life. This is just the tip of the iceberg, with the other modules soon to be released (i.e. diabetes, hypertension, glaucoma, etc), the number of patients Retinalyze, LLC can impact worldwide is absolutely staggering.”

Stephen D. Barnhill, M.D., Chairman and CEO of Health Discovery Corporation, states, “We are extremely pleased with this partnership with the National Coalition of Eye Care IPAs with their 5,500 member doctors and the immediate and significant revenue this group can generate. In addition, we are also in discussions with large Ophthalmology groups and expect to be executing contracts with these physician groups in the very near future." Dr. Barnhill continued, "It is very exciting to see how quickly the ophthalmic community is embracing this SVM based macular degeneration tool and we are thrilled to now have so many established customers who are looking forward to purchasing our upcoming products using similar fundoscopic images to evaluate patients with diabetes, hypertension, glaucoma, and others."

Eye Doctors and patients interested in learning more about the NATIONAL EYEPA COALITION, please visit www.nationaleyepa.com.

About Doctors Optimal Formula LLC

Having been founded by medical doctors, Doctors Optimal Formula prides itself on providing the best, scientifically formulated nutritional supplements and anti-aging skin care available today! Focusing on maintaining and improving the health and well being of our customers, Doctors Optimal Formula has become vertically integrated to encompass all aspects of healthcare, such as Vision Care Plans, Prescription Pharmacy Plans and a physician provider network of over 10,000 physicians. For more information, visit www.DoctorsOptimalFormula.com.

About Health Discovery Corporation

Health Discovery Corporation is a molecular diagnostics company that uses advanced mathematical techniques to analyze large amounts of data to uncover patterns that might otherwise be undetectable. It operates primarily in the emerging field of personalized medicine where such tools are critical to scientific discovery. Its primary business consists of licensing its intellectual property and developing its own product line of biomarker-based diagnostic tests that include human genes and genetic variations, as well as gene, protein, and metabolic expression differences and image analysis in digital pathology and radiology. For more information, see www.healthdiscoverycorp.com.

Forward-Looking Statements

This document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, the accuracy of which is necessarily subject to risks and uncertainties, including, without limitation, statements regarding future performance, opportunities and investments, and anticipated results in general. From time to time the Company may make other forward-looking statements in relation to other matters, including without limitation, commercialization plans and strategic partnerships. Actual results may differ materially due to a variety of factors, including, among other things, the acceptance of our approach to applying mathematics, computer science and physics into the disciplines of biology, organic chemistry and medicine and our products and technologies associated with those approaches, the ability to develop and commercialize new drugs, therapies or other products based on our approaches, and other factors set forth from time to time in the Company’s Securities and Exchange Commission filings.

All forward-looking statements and cautionary statements included in this document are made as of the date hereof based on information available to the Company as of the date hereof, and the Company assumes no obligation to update any forward-looking statement or cautionary statement.

Copyright Business Wire 2010